YorkBridge Wealth Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$270K Buy
1,335
+117
+10% +$22.9K 0.07% 212
2022
Q3
$214K Buy
1,218
+6
+0.5% +$1.23K 0.06% 255
2022
Q2
$244K Hold
1,212
0.06% 238
2022
Q1
$274K Buy
1,212
+120
+11% +$28.2K 0.06% 251
2021
Q4
$295K Hold
1,092
0.07% 234
2021
Q3
$264K Hold
1,092
0.07% 228
2021
Q2
$259K Hold
1,092
0.07% 223
2021
Q1
$239K Buy
+1,092
New +$219K 0.07% 224
2018
Q3
Sell
-45
Closed -$7K 804
2018
Q2
$7K Hold
45
﹤0.01% 660
2018
Q1
$6K Hold
45
﹤0.01% 670
2017
Q4
$6K Hold
45
﹤0.01% 687
2017
Q3
$6K Buy
+45
New +$6K ﹤0.01% 693
2017
Q2
Sell
-29
Closed -$4K 891
2017
Q1
$4K Hold
29
﹤0.01% 711
2016
Q4
$3K Buy
+29
New +$3.22K ﹤0.01% 719

Other funds holding LH

YorkBridge Wealth Partners's LH Position: Q4 2022 in Review

YorkBridge Wealth Partners increased its Labcorp (LH) stake by 9.6% in Q4 2022, buying an estimated $22.9K and bringing the position to 1,335 shares worth $270K. The position accounts for 0.07% of the portfolio, ranked #212.

YorkBridge Wealth Partners first reported a position in LH in Q4 2016 and has held it in 14 quarters since. The position peaked at $295K in Q4 2021. 969 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • YorkBridge Wealth Partners held 1,335 shares of Labcorp worth $270K as of Q4 2022.
  • YorkBridge Wealth Partners bought 117 Labcorp shares in Q4 2022, an estimated $22.9K.
  • Labcorp made up 0.07% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #212 holding.
  • YorkBridge Wealth Partners first reported a position in Labcorp in Q4 2016 and has held it in 14 quarters since.
  • YorkBridge Wealth Partners's Labcorp position peaked at $295K in Q4 2021.
  • 969 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.